CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:  Zhang, Wei;  Gao, Yuhuan;  Jin, Zhengming;  Zhou, Jianfeng;  Jin, Chuan
收藏  |  浏览/下载:46/0  |  提交时间:2019/12/05
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4
作者:  Xiao, Xiubin;  Bao, Huizheng;  Wang, Ningju;  Ren, Hanyun;  Cen, Xinan
收藏  |  浏览/下载:59/0  |  提交时间:2019/12/05
Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure 期刊论文
CANCER SCIENCE, 2018, 卷号: 109, 期号: 12
作者:  Zhang, Wei;  Jia, Jing;  Bai, Ou;  Yang, Sheng;  Liang, Rong
收藏  |  浏览/下载:42/0  |  提交时间:2019/12/05
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10
作者:  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu;  Liu, Ting
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS) 期刊论文
BLOOD, 2016, 卷号: 128, 期号: 22
作者:  Hu, Shaoxuan;  Song, Yuqin;  Li, Yufu;  Sun, Xiuhua;  Su, Liping
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression 期刊论文
NATURE COMMUNICATIONS, 2014, 卷号: 5
作者:  Lu, Yong;  Zhang, Mingjun;  Wang, Siqing;  Hong, Bangxing;  Wang, Zhiqiang
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace